REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $503,881 | -7.9% | 3,562 | +9.7% | 0.10% | -14.8% |
| Q1 2023 | $546,833 | +3.3% | 3,248 | +3.9% | 0.12% | +6.5% |
| Q4 2022 | $529,263 | -11.8% | 3,126 | -2.4% | 0.11% | -18.8% |
| Q3 2022 | $600,000 | +14.1% | 3,204 | -1.1% | 0.13% | +17.7% |
| Q2 2022 | $526,000 | -13.6% | 3,239 | 0.0% | 0.11% | +8.7% |
| Q1 2022 | $609,000 | -38.5% | 3,239 | -13.5% | 0.10% | -27.8% |
| Q4 2021 | $991,000 | -9.2% | 3,743 | -0.9% | 0.14% | -12.7% |
| Q3 2021 | $1,092,000 | +42.6% | 3,778 | -1.6% | 0.16% | +42.2% |
| Q2 2021 | $766,000 | -82.6% | 3,839 | -83.0% | 0.12% | -85.3% |
| Q1 2021 | $4,397,000 | +6.3% | 22,617 | +4.8% | 0.79% | +5.6% |
| Q4 2020 | $4,136,000 | +735.6% | 21,584 | +542.8% | 0.75% | +593.5% |
| Q3 2020 | $495,000 | -15.7% | 3,358 | -29.3% | 0.11% | -22.3% |
| Q2 2020 | $587,000 | +33.1% | 4,749 | +4.0% | 0.14% | +33.7% |
| Q1 2020 | $441,000 | +2.3% | 4,565 | -2.1% | 0.10% | +50.7% |
| Q4 2019 | $431,000 | -60.1% | 4,661 | -66.9% | 0.07% | -61.5% |
| Q3 2019 | $1,080,000 | +66.9% | 14,088 | +87.0% | 0.18% | +79.0% |
| Q2 2019 | $647,000 | – | 7,532 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |